← Eichor
Condition: Overweight And Obese Volunteers Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Overweight And Obese Volunteers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participant
Phase 1/Phase 2 · 1 location(s) · MindRank AI Ltd · NCT06778850A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Phase 1/Phase 2 · 5 location(s) · Arrowhead Pharmaceuticals · NCT06700538A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity
Phase 1 · 2 location(s) · Hoffmann-La Roche · NCT07499050Physical and Behavioral Traits of Overweight and Obese Adults
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00428987L. Acidophilus (Strain TW01) on Gut Health, Body Composition, and Inflammation
EARLY_Phase 1 · 1 location(s) · University of Connecticut · NCT06912100Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
Phase N/A · 1 location(s) · Richmond Research Institute · NCT04873258A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With
Phase 1 · 3 location(s) · Boehringer Ingelheim · NCT07693231New Heart Imaging Techniques to Evaluate Possible Heart Disease
NA · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT01399385Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZT003 Injection Following Single and Multiple Subcut
Phase 1 · 2 location(s) · Beijing QL Biopharmaceutical Co.,Ltd · NCT07184502Diabetes and Heart Disease Risk in Blacks
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00001853Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
NA · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT06223555A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection
Phase 1 · 1 location(s) · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT06934408A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesi
Phase 1 · 1 location(s) · Novo Nordisk A/S · NCT07578584Taste Physiology in Obese Volunteers Before and After Bariatric Surgery
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT02902198Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of R
Phase 1/Phase 2 · 1 location(s) · Ikaria Bioscience Pty Ltd · NCT07245771A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Phase 1/Phase 2 · 8 location(s) · Arrowhead Pharmaceuticals · NCT06937203A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy A
Phase 1 · 1 location(s) · AbbVie · NCT07514260A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Phase 3 · 10 location(s) · Vanda Pharmaceuticals · NCT07446439Children s Growth and Behavior Study
Phase N/A · 1 location(s) · Eunice Kennedy Shriver National Institute of Child Health an · NCT02390765A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Hea
Phase 1 · 1 location(s) · Daewoong Pharmaceutical Co. LTD. · NCT07539415Evaluate LAE102 in Healthy and Overweight/Obese Subjects
Phase 1 · 1 location(s) · Laekna Limited · NCT06493084An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers.
Phase 1 · 1 location(s) · RANI Therapeutics · NCT06891287The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
NA · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05545306
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.